1 follower
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.
Aetna Wun Trombley
Cellphire Therapeutics
3 followers
Entos
1 follower
Thermo Fisher Scientific
166 followers
Regeneron
94 followers
Agilent Technologies
63 followers
Alexion Pharmaceuticals
34 followers
Charles River Laboratories
11 followers
Cytiva
10 followers
Calico
6 followers
Merck
216 followers
AbbVie
178 followers
Explore companies